Miecz D, Januszewicz E, Czeredys M, Hinton BT, Berezowski V, Cecchelli R, et al
Researchers may explore BPC-157 in studies involving fibroblast activity, angiogenic markers, epithelial response, and broader regenerative pathway observation at the molecular level
Heres the real science, the actual mechanisms, and the critical limitations you MUST understand about this newest form of administering BPC-157
(Those who did not respond well to azithromycin did not.) Fibromyalgia and Chronic Pain A metareview of 18 metabolomics studies suggested that altered acetylcarnitine metabolites may play a role in chronic pain A 102-person, double-blinded , 2007 Italian fibromyalgia study found that 2 capsules/day of 500 mg of acetyl-L-carnitine (LAC) plus one intramuscular (i.m.) injection of 500 mg LAC for the first 2 weeks, plus 3 500 mg capsules daily for the next 8 weeks resulted in significant improvements in visual analogue pain scores for both the treated and the placebo group